By proceeding, you agree to our Terms of Use and Privacy Policy.
Join us for an informative event, in partnership with the Tufts Center for the Study of Drug Development, where we will delve into the latest trends impacting clinical trial research. Gain valuable insights on how to leverage the benefits of decentralized and hybrid clinical trials, and confidently run your next trial. Craig Lipset, an expert in decentralized clinical trials, will explore the next generation of DCTs, including stabilizing DCT 1.0 and advancing DCT 2.0. Kenneth Getz from Tufts University School of Medicine will provide an in-depth analysis of the value proposition of DCT deployments in clinical trials. In addition, CSL Behring will share their experience in establishing the framework for DCTs, lessons learned, and future visions. Join our lively panel discussion and unravel the hype from the reality. Discover the actual value proposition of decentralized and hybrid clinical trials and how they can benefit your research. Don't miss this opportunity to stay up-to-date with the latest trends in clinical trial research.
Learn about the latest trends and developments impacting clinical trial research.
Gather valuable insights on decentralized trials, the value proposition of DCT deployments, complexities of digital health measurement and more.
Participate in keynote sessions by industry experts to achieve the promise of digital solutions to improve diversity, equity, and inclusion in clinical trials
Hear from healthcare practitioners to explore the real value of decentralized and quantify the value proposition of DCT deployments in clinical trials.
We are the world’s leading producer of live events and digital communities, where professionals share knowledge and make connections to help them grow professionally and commercially.
Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, we provide access to patients who can never be reached by traditional site-based models.
We’re on a mission to make life better for patients taking part in clinical trials around the world, and their caregivers.
ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to pharmaceutical, biotechnology, medical device, and government and public health organisations.
Medocity is a health technology company and the leading cloud-based enterprise platform provider combining integrated AI with multiple virtual care capabilities to transform management of chronic and complex disease – a comprehensive, patient-centere
Offering You Peace of Mind to Focus on Your Patients Suvoda’s sole focus is to offer the industry’s leading SaaS solution for randomization and trial supply management.
"Cambridge Cognition Plc (AIM: COG) is an international digital neuroscience company developing and marketing validated software technologies to enhance research into brain health, optimise R&D productivity and precisely quantify cognition in patient
CMIC Group was the first company to provide CRO (contract research organization) services in Japan. Relevant laws and rules had not been established when the group was first established.
1nHealth exists to fill clinical research studies. We do this in a class leading way across two key parameters: cost per enrollment efficiency and capacity to deliver the highest enrollment volumes.
OneStudyTeam, a member of the Reify Health family, provides the cloud-based platform StudyTeam to accelerate the development of new and life-saving therapies.
Precision Digital Health accelerates the adoption of digital health in research by providing a low barrier of entry analytics as a service with its Big Data platform, SUMMA™. SUMMA™ enables the convergence of real-world patient data from various sour
Precision Digital Health accelerates the adoption of digital health in research by providing a low barrier of entry analytics as a service with its Big Data platform, SUMMA™. SUMMA™ enables the convergence of real-world patient data from various sources like the electronic health record (EHR), as we
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.